ArticleAdvanced intelligent systems (Weinheim an der Bergstrasse, Germany)2026
RPSLearner: A Novel Approach Based on Random Projection and Deep Stacking Learning for Categorizing Non-Small Cell Lung Cancer.
Article in Advanced intelligent systems (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- RaMBat: Accurate identification of medulloblastoma subtypes from diverse data sources with severe batch effects.Molecular oncology · 2026Article
- MetaPaCS: A Novel Meta-Learning Framework for Pancreatic Cancer Subtype Identification.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
- Update of
Authors and funding
3 authors.
Funding
Abstract
Non-small cell lung cancer (NSCLC) comprises the largest subtype of lung cancer with the most cases. Lung adenocarcinoma and lung squamous cell carcinoma are two NSCLC subtypes that pose challenges for accurate diagnosis using conventional methods, including histological examination and imaging, which can be slow and inconclusive. To address these concerns, RPSLearner is proposed, which combines random projection (RP) for dimensionality reduction and stacking ensemble learning to accurately predict lung cancer subtypes. Specifically, multiple independent RP matrices are first generated to project the high-dimensional RNA-seq data into a lower-dimensional space, whose features are subsequently concatenated. After that, the concatenated RP features are fed into a stack of diverse base classifiers, and integrated the predictions from base models via a deep linear layer network. Benchmarking tests on 1 333 NSCLC patients demonstrated that RPSLearner outperformed state-of-the-art approaches for lung cancer subtype classification. Specifically, RPSLearner efficiently preserved sample-to-sample distances even after significant dimension reduction, and the meta-model in RPSLearner yielded consistently higher scores than individual base models. In addition, the feature fusion method outperformed conventional score ensemble methods. We believe RPSLearner is a promising model for downstream lung cancer clinical diagnosis, and it holds the potential to be extended to subtyping of other types of cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.